NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Consortium Québécois sur la découverte du médicament

Consortium Québécois sur la découverte du médicament

Quebeccqdm.org

Overview

CQDM is a non-profit biopharmaceutical research consortium whose mission is to support and facilitate multi-stakeholder collaborative R&D that accelerates translation of leading-edge discoveries into vaccines, therapeutics and diagnostics addressing unmet medical needs while generating significant benefits for the Canadian economy. CQDM deploys R&D funding programs that focus on accelerating the translation of innovation into socio-economic outcomes and health benefits for our population.

Year Founded

2008

Portfolio Companies

28

Website

cqdm.org

Investments

Consortium Québécois sur la découverte du médicament investments
CompanyDateStageLead
MISO ChipJul 2026GrantCo-investor
DropGenieJun 2026SeedCo-investor
TATUM BioscienceJun 2026GrantCo-investor
RIME TherapeuticsApr 2026SeedCo-investor
WhelixMar 2026AcceleratorCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersQuebec
Year Founded2008

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.